[go: up one dir, main page]

BR9713653B1 - composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico. - Google Patents

composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.

Info

Publication number
BR9713653B1
BR9713653B1 BRPI9713653-0A BR9713653A BR9713653B1 BR 9713653 B1 BR9713653 B1 BR 9713653B1 BR 9713653 A BR9713653 A BR 9713653A BR 9713653 B1 BR9713653 B1 BR 9713653B1
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
preparing
ferric pyrophosphate
dialysis
soluble
Prior art date
Application number
BRPI9713653-0A
Other languages
English (en)
Other versions
BR9713653A (pt
Inventor
Ajay Gupta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/775,595 external-priority patent/US6689275B1/en
Application filed filed Critical
Publication of BR9713653A publication Critical patent/BR9713653A/pt
Publication of BR9713653B1 publication Critical patent/BR9713653B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
BRPI9713653-0A 1996-12-31 1997-12-30 composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico. BR9713653B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/775,595 US6689275B1 (en) 1996-12-31 1996-12-31 Method and pharmaceutical composition for replacing iron losses in dialysis patients
US5531597P 1997-08-07 1997-08-07
PCT/US1997/023719 WO1998029434A1 (en) 1996-12-31 1997-12-30 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients

Publications (2)

Publication Number Publication Date
BR9713653A BR9713653A (pt) 2000-04-11
BR9713653B1 true BR9713653B1 (pt) 2013-05-21

Family

ID=26734087

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9713653-0A BR9713653B1 (pt) 1996-12-31 1997-12-30 composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.

Country Status (17)

Country Link
EP (1) EP0951470B1 (pt)
JP (2) JP3955639B2 (pt)
AT (1) ATE311180T1 (pt)
AU (1) AU736053B2 (pt)
BR (1) BR9713653B1 (pt)
CA (1) CA2276442C (pt)
DE (1) DE69734781T2 (pt)
DK (1) DK0951470T3 (pt)
EA (1) EA002479B1 (pt)
ES (1) ES2255115T3 (pt)
NO (1) NO317873B1 (pt)
NZ (1) NZ336319A (pt)
PL (1) PL191377B1 (pt)
SI (1) SI20151A (pt)
TR (1) TR199901518T2 (pt)
WO (1) WO1998029434A1 (pt)
YU (1) YU31299A (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
CA2422850C (en) 1999-09-22 2009-03-03 Advanced Renal Technologies High citrate dialysate and uses thereof
DE19951471A1 (de) * 1999-10-26 2001-05-03 Forssmann Wolf Georg Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
CA2544235C (en) * 2003-10-28 2013-12-10 Emory University Dialysates and methods and systems related thereto
US8187467B2 (en) 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
SE0400523D0 (sv) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
US7586589B2 (en) * 2005-09-24 2009-09-08 Beckman Coulter, Inc. Methods of determination of responsiveness to erythropoietin treatment
US7816404B2 (en) * 2007-07-20 2010-10-19 Rockwell Medical Technologies, Inc. Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
US20110262555A1 (en) * 2010-04-23 2011-10-27 Baxter Healthcare S.A. Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
AU2015200995B2 (en) * 2010-04-23 2016-09-08 Vantive Health Gmbh Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
CA2900043A1 (en) * 2013-02-01 2014-08-07 Charak Llc Methods of treating iron deficiency with soluble ferric pyrophosphate
US20160250254A1 (en) * 2013-11-05 2016-09-01 Rockwell Medical, Inc. Methods of reducing doses of erythropoietin stimulating agents in hyporesponsive patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3530216A (en) * 1967-10-05 1970-09-22 Hoffmann La Roche Vitamin compositions comprising riboflavin-5-phosphate and ferric pyrophosphate soluble
US3911915A (en) * 1972-09-05 1975-10-14 Einstein Coll Med Dialytic introduction of maltose into bloodstream
JPS5125238B2 (pt) * 1973-08-14 1976-07-29
US4756838A (en) * 1980-02-21 1988-07-12 Veltman Preston Leonard Preparation of dry dialysate products
JPH0696586B2 (ja) * 1987-03-17 1994-11-30 花王株式会社 ヘキソ−スリン酸第一鉄塩及びその製造法並びにこれを含有する鉄供給剤
JPH0525051A (ja) * 1991-07-19 1993-02-02 Meiji Seika Kaisha Ltd 貧血予防・治療剤
JP3167402B2 (ja) * 1992-02-25 2001-05-21 仙味エキス株式会社 鉄吸収促進組成物

Also Published As

Publication number Publication date
YU31299A (sh) 2002-08-12
DE69734781D1 (de) 2006-01-05
EP0951470B1 (en) 2005-11-30
ES2255115T3 (es) 2006-06-16
EP0951470A1 (en) 1999-10-27
DK0951470T3 (da) 2006-03-27
EA002479B1 (ru) 2002-06-27
AU5617298A (en) 1998-07-31
HK1023350A1 (en) 2000-09-08
WO1998029434A1 (en) 1998-07-09
NZ336319A (en) 2000-12-22
AU736053B2 (en) 2001-07-26
DE69734781T2 (de) 2006-07-20
CA2276442C (en) 2012-01-17
EA199900609A1 (ru) 1999-12-29
BR9713653A (pt) 2000-04-11
NO317873B1 (no) 2004-12-27
NO993235D0 (no) 1999-06-29
JP2002531051A (ja) 2002-09-17
PL191377B1 (pl) 2006-05-31
JP2007106775A (ja) 2007-04-26
JP3955639B2 (ja) 2007-08-08
EP0951470A4 (en) 2003-05-02
ATE311180T1 (de) 2005-12-15
NO993235L (no) 1999-08-27
JP4753379B2 (ja) 2011-08-24
CA2276442A1 (en) 1998-07-09
SI20151A (sl) 2000-08-31
TR199901518T2 (xx) 1999-12-21
PL334437A1 (en) 2000-02-28

Similar Documents

Publication Publication Date Title
BR9713653B1 (pt) composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.
IE790952L (en) Acyl-carnitine solutions for haemodialysis
PT1218039E (pt) Utilização dum dialisado com alto teor de citrato
BR9804330A (pt) Solução para diálise transperitoneal.
AU4553700A (en) Substitution infusion fluid and citrate anticoagulation
IL140848A0 (en) Treatment regimen for administration of phenylacetylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
MY125984A (en) Pharmaceutical solutions of levosimendan.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
IE821162L (en) Dialysis solution
DE60025698D1 (de) Neue dialysemethode
SE9600631D0 (sv) Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
SI1220670T1 (sl) Uporaba L-karnitina in njegovih alkanoil derivatov kot ozmotsko sredstvo za medicinske namene
ES2183417T3 (es) Concentrado para solucion medica y su utilizacion.
NO20002008L (no) Løsning for peritonealdialyse og fremgangsmÕte for fremstilling derav
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy
RU96104214A (ru) Способ лечения транссудативных форм центральных хориоретинальных дистрофий
Maha et al. < The> therapeutic effects of once daily dose doxazosin; a selective alpha, adrenoceptor inhibitor, on blood pressure and serum lipid pattern
RU97111211A (ru) Способ лечения больных с хирургическим эндотоксикозом
HUP9902859A2 (hu) Eljárás és berendezés vörösvértest-helyettesítő készítmények előállítására
UA30184A (uk) Спосіб рефлексотерапії хворих з віддаленими наслідками черепно-мозкової травми

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 23A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2611 DE 19-01-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.